Literature DB >> 12679617

Intra-arterial bone marrow cell transplantation induces angiogenesis in rat hindlimb ischemia.

M Yoshida1, H Horimoto, S Mieno, Y Nomura, H Okawa, K Nakahara, S Sasaki.   

Abstract

BACKGROUND: Bone marrow (BM) cells have been shown to augment local angiogenesis by differentiating vessels themselves and/or secreting paracrinally angiogenic growth factors. Herein, the angiogenic effects of intra-arterial BM mononuclear cell (BM-MNC) transplantation were evaluated in a rat ischemic hindlimb model.
METHODS: Unilateral hindlimb ischemia was created by excising the femoral artery and its branch in Lewis rats. BM-MNCs were isolated by centrifugation through a Histopaque density gradient. One week after excision of the unilateral femoral artery, BM-MNCs (5 x 10(6) cells, Group A, n = 6) or PBS (Group B, n = 7) were injected into the ischemic thigh skeletal muscles at the six points with a gauge needle. Another injection of BM-MNCs (3 x 10(7) cells, Group C, n = 6) or PBS (Group D, n = 7) was administered via the indwelling catheter in the right common iliac artery.
RESULTS: Four weeks after the BM-MNC transplantation, angiographic examination revealed the development of collateral vessels in both BM-MNC-transplanted groups. The difference in skin temperature between right and left hindlimbs was significantly reduced in both BM-MNC-transplanted groups (0.93 +/- 0.15 vs. 2.84 +/- 0.35 vs. 1.20 +/- 0.26 vs. 2.61 +/- 0.37 degrees C, Group A vs. Group B vs. Group C vs. Group D, p < 0.05). Moreover, immunohistochemical analysis demonstrated that capillary endothelial cells were increased in both BM-MNC-transplanted groups.
CONCLUSION: BM-MNC implantation was able to induce functional neovascularization in rat ischemic hindlimb. The intra-arterial administration offered similar levels of angiogenic activity as intramuscular injection. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679617     DOI: 10.1159/000069401

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  5 in total

1.  Noninvasive management of the diabetic foot with critical limb ischemia: current options and future perspectives.

Authors:  Mathias Weck; Torsten Slesaczeck; Hannes Rietzsch; Dirk Münch; Thomas Nanning; Hartmut Paetzold; Hans-Joachim Florek; Andreas Barthel; Norbert Weiss; Stefan Bornstein
Journal:  Ther Adv Endocrinol Metab       Date:  2011-12       Impact factor: 3.565

2.  CXCR4 Overexpression in Human Adipose Tissue-Derived Stem Cells Improves Homing and Engraftment in an Animal Limb Ischemia Model.

Authors:  MiJung Kim; Dong-Ik Kim; Eun Key Kim; Chan-Wha Kim
Journal:  Cell Transplant       Date:  2016-08-05       Impact factor: 4.064

Review 3.  Therapeutic myocardial angiogenesis: past, present and future.

Authors:  Mickey Scheinowitz
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

4.  A Swine Hind Limb Ischemia Model Useful for Testing Peripheral Artery Disease Therapeutics.

Authors:  Juline N Deppen; Sydney C Ginn; Na Hee Kim; Lanfang Wang; Ronald J Voll; Steven H Liang; Mark M Goodman; John N Oshinski; Rebecca D Levit
Journal:  J Cardiovasc Transl Res       Date:  2021-05-28       Impact factor: 4.132

5.  REX-001, a BM-MNC Enriched Solution, Induces Revascularization of Ischemic Tissues in a Murine Model of Chronic Limb-Threatening Ischemia.

Authors:  Marta Rojas-Torres; Margarita Jiménez-Palomares; Javier Martín-Ramírez; Lucía Beltrán-Camacho; Ismael Sánchez-Gomar; Sara Eslava-Alcon; Antonio Rosal-Vela; Sandra Gavaldá; Mª Carmen Durán-Ruiz
Journal:  Front Cell Dev Biol       Date:  2020-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.